GLP-1 Telehealth for Beginners: Where to Start in 2026

You've heard about GLP-1 medications. You're interested. But you've never used a telehealth platform for prescription medication, and the sheer number of options is overwhelming. This guide is for you — a straightforward walkthrough of how to get started, written for someone who's done zero research beyond "I might want to try this."

Am I Eligible?

GLP-1 medications are FDA-approved for weight management in adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition (high blood pressure, type 2 diabetes, high cholesterol, sleep apnea). Most telehealth platforms follow these same criteria.

You should not take GLP-1 medications if you have a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN-2), a history of pancreatitis, or are pregnant or planning to become pregnant. Your telehealth prescriber will screen for all of these — but know them in advance so nothing catches you off guard.

Brand-Name vs. Compounded: The First Decision

This is the most important fork in the road, and no one explains it well enough to beginners.

Brand-name medications (Wegovy, Ozempic, Zepbound, Mounjaro) are FDA-approved. They've been through extensive clinical trials. They come in pre-filled pens — you click and inject, no measuring required. They cost $1,000–1,300/month without insurance. With insurance coverage (when available), copays range from $25 to $200/month.

Compounded medications use the same active ingredient (semaglutide or tirzepatide) prepared by a licensed compounding pharmacy. They are not FDA-approved. They come in multi-dose vials — you draw your dose with a syringe. They cost $130–250/month through telehealth platforms, no insurance required.

The active ingredient is the same. The difference is FDA approval, the delivery device, and the price. For most patients without insurance coverage, compounded is the practical choice. If you have insurance that covers GLP-1s with a reasonable copay, brand-name is the premium option.

Semaglutide vs. Tirzepatide: The Second Decision

Semaglutide (brand names: Wegovy for weight loss, Ozempic for diabetes) is a GLP-1 receptor agonist. Clinical trials show average weight loss of about 15% of body weight over 68 weeks. It's the most widely prescribed and most studied GLP-1 for weight loss.

Tirzepatide (brand names: Zepbound for weight loss, Mounjaro for diabetes) is a dual GIP/GLP-1 receptor agonist. Clinical trials show higher average weight loss — up to 22.5% of body weight. It's newer, with somewhat less long-term data than semaglutide, but the weight loss results are consistently stronger in head-to-head studies.

For beginners, semaglutide is often the starting recommendation because of its extensive safety data and lower cost for compounded versions. Tirzepatide is the step-up option if semaglutide results plateau or if your prescriber recommends a more aggressive approach.

What to Expect in the First Month

Weeks 1–2: You start at the lowest dose (0.25 mg/week for semaglutide, 2.5 mg/week for tirzepatide). Many patients notice reduced appetite within the first week. Some experience mild nausea, especially after meals. Appetite suppression is the mechanism — you'll simply feel less hungry and more satisfied with smaller portions.

Weeks 3–4: Side effects typically stabilize. The most common — nausea, constipation, mild fatigue — are usually manageable and improve as your body adjusts. Weight loss in the first month is typically 3–6 pounds, though individual variation is significant.

What to eat: Eat protein first (at least 60–80 grams per day), eat slowly, stop when you feel full. Avoid greasy, fatty foods that worsen nausea. Stay hydrated — dehydration from reduced intake is the most common and most preventable side effect. A 2026 review in Obesity Reviews found that patients on GLP-1 medications often develop nutrient deficiencies because they eat so much less. Protein and hydration are non-negotiable.

Our Picks for First-Time Patients

Embody is our top recommendation for beginners. The intake process is clear, prescribers explain the titration schedule in detail, and the $149/month entry point is accessible. Injectable semaglutide with structured clinical follow-up.

Gala's flat-rate pricing ($179/month at any dose) eliminates the uncertainty of cost increases as you titrate up — one less thing to worry about when you're new to the process.

If you prefer brand-name, FDA-approved medication, Sesame Care is the best entry point. $29 consultations with prescribers who can write for Wegovy, Ozempic, or Zepbound.